June 28, 2019 Price forecast | 2 weeks: 6.50% | 1 month: 7.11% | 3 months: 9.07%


VRML stock forecast

Our latest prediction for Vermillion, Inc.'s stock price was made on the June 28, 2019 when the stock price was at 0.89$.

In the short term (2weeks), VRML's stock price should outperform the market by 6.50%. During that period the price should oscillate between -9.29% and +19.42%.

In the medium term (3months), VRML's stock price should outperform the market by 9.07%. During that period the price should oscillate between -22.54% and +54.36%.


About Vermillion, Inc.

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.

At the moment the company generates 3M USD in revenues.

On its last earning announcement, the company reported a loss of -0.16$ per share.

The book value per share is 0.16$

Vermillion, Inc. website


Three months stock forecastJune 28, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
3M 5.40% -12M -380.90% -12M -0.16 - - 74M 0.16 -10M - -10M